|
1000
|
Abstract/Summary
|
-
The Post-COVID Syndrome (PCS) can vary greatly in severity, but is usually accompanied by severe fatigue. Some of those affected suffer from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Knowledge about targeted therapies for both conditions is still in its infancy. Little is known about the exact disease mechanisms of ME/CFS and Post-COVID syndrome. Therefore, no targeted medical treatments exist. As a result, many people with ME/CFS are perpetually ill and unable to work or to take care of their families. Researchers at Charité - Universitätsmedizin Berlin have now founded a National Clinical Study Group to conduct the first clinical trials with drugs for the treatment of PCS and ME/CFS. Prof. Scheibenbogen's study group wants to initiate and conduct first clinical trials with drugs and medical procedures for PCS and ME/CFS. The aim is to receive approval for effective therapies to make them available to all patients. The focus is on drugs that are already available for other diseases to achieve rapid progress in treatment. In this webinar, Prof. Scheibenbogen introduces the study group and its goals. She will explain how the process of enrolling patients and conducting the studies is planned and when first results can be expected.
|
